Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AristaTM in Mastectomies
NCT06824831Phase 4Completed
- Sponsor
- INCLIVA Biomedical Research Institute
- Start
- Jun 2020
- Primary completion
- Jul 2022
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by INCLIVA Biomedical Research Institute. Primary endpoint: Incidence of patients presenting seroma formation after mastectomy with or without axillary lymphadenectomy at 2 years. Started Jun 2020; status: completed.
Beyond the preview
Go deeper on NCT06824831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06824831.